ETF Holdings Breakdown of TBPH

Stock Name	Theravance Biopharma Inc
Ticker	TBPH(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	KYG8807B1068
LEI	5493007VTSXP4Z6MIW52

TBPH institutional holdings

The following institutional investment holdings of TBPH have been identified

Date ETF ISIN/Name Num Shares Book value Derived Price per Share Comment
2025-11-12 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 32,443 USD 576,837 17.78

2025-11-12 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 32,443 0.3% USD 576,837 -3.8% 17.78

Total = 64,886 USD 1,153,674
Book value of shares is calculated on the adjusted close price of each day (row).

Date	ETF ISIN/Name	Num Shares	Book value	Derived Price per Share
2025-11-12	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	32,443	USD 576,837	17.78
2025-11-12	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	32,443 0.3%	USD 576,837 -3.8%	17.78
Total =	64,886	USD 1,153,674

News associated with TBPH

Theravance Biopharma, Inc. (NASDAQ:TBPH) Short Interest Up 25.3% in August: Theravance Biopharma, Inc. (NASDAQ:TBPH – Get Free Report) was the target of a significant increase in short interest in August. As of August 31st, there was short interest totaling 4,460,000 shares, an increase of 25.3% from the August 15th total of 3,560,000 shares. Based on an average trading volume of 333,700 shares, the short-interest ratio […] - 2025-09-19 04:28:56
Theravance Biopharma, Inc. (NASDAQ:TBPH) Given Average Recommendation of “Strong Buy” by Analysts: Theravance Biopharma, Inc. (NASDAQ:TBPH – Get Free Report) has been given an average recommendation of “Strong Buy” by the five brokerages that are covering the firm, Marketbeat reports. Two research analysts have rated the stock with a buy rating and three have given a strong buy rating to the company. The average 12-month target price […] - 2025-09-17 02:58:46
Theravance Biopharma (NASDAQ:TBPH) Hits New 1-Year High Following Strong Earnings: Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH – Get Free Report) hit a new 52-week high during mid-day trading on Tuesday following a stronger than expected earnings report. The stock traded as high as $11.88 and last traded at $11.89, with a volume of 195285 shares. The stock had previously closed at $11.40. The biopharmaceutical company […] - 2025-08-13 02:58:43
Bank of New York Mellon Corp Raises Holdings in Theravance Biopharma, Inc. (NASDAQ:TBPH): Bank of New York Mellon Corp grew its stake in shares of Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) by 1.5% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 117,499 shares of the biopharmaceutical company’s stock after buying an additional 1,720 shares during the […] - 2025-08-01 04:26:59
Theravance Biopharma, Inc. (NASDAQ:TBPH) Shares Bought by GSA Capital Partners LLP: GSA Capital Partners LLP raised its position in Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) by 11.9% during the 1st quarter, HoldingsChannel.com reports. The firm owned 182,350 shares of the biopharmaceutical company’s stock after acquiring an additional 19,363 shares during the period. GSA Capital Partners LLP’s holdings in Theravance Biopharma were worth $1,628,000 at the […] - 2025-07-30 04:44:43
Alps Advisors Inc. Sells 3,680 Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH): Alps Advisors Inc. decreased its position in shares of Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) by 9.3% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 36,079 shares of the biopharmaceutical company’s stock after selling 3,680 shares during the period. […] - 2025-07-18 04:49:01
Theravance Biopharma, Inc. (NASDAQ:TBPH) Given Consensus Recommendation of “Moderate Buy” by Analysts: Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the six brokerages that are presently covering the firm, MarketBeat reports. Three investment analysts have rated the stock with a hold recommendation, two have assigned a buy recommendation and one has given a strong buy recommendation […] - 2025-07-17 04:40:54
Jones Trading Initiates Coverage on Theravance Biopharma (NASDAQ:TBPH): Jones Trading initiated coverage on shares of Theravance Biopharma (NASDAQ:TBPH – Get Free Report) in a note issued to investors on Tuesday,Benzinga reports. The firm set a “buy” rating and a $24.00 price target on the biopharmaceutical company’s stock. Jones Trading’s target price suggests a potential upside of 125.99% from the stock’s current price. TBPH […] - 2025-06-19 02:18:55
Wellington Management Group LLP Acquires 7,162 Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH): Wellington Management Group LLP raised its stake in shares of Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) by 3.7% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 198,491 shares of the biopharmaceutical company’s stock after buying an additional 7,162 shares during […] - 2025-06-06 06:12:49
Public Employees Retirement System of Ohio Buys New Position in Theravance Biopharma, Inc. (NASDAQ:TBPH): Public Employees Retirement System of Ohio bought a new stake in shares of Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 37,461 shares of the biopharmaceutical company’s stock, valued at approximately $353,000. Other hedge funds […] - 2025-06-05 06:14:52
Squarepoint Ops LLC Has $444,000 Position in Theravance Biopharma, Inc. (NASDAQ:TBPH): Squarepoint Ops LLC cut its position in shares of Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) by 52.3% in the fourth quarter, Holdings Channel reports. The institutional investor owned 47,168 shares of the biopharmaceutical company’s stock after selling 51,783 shares during the period. Squarepoint Ops LLC’s holdings in Theravance Biopharma were worth $444,000 as of […] - 2025-06-05 05:16:56
ProShare Advisors LLC Acquires New Position in Theravance Biopharma, Inc. (NASDAQ:TBPH): ProShare Advisors LLC acquired a new stake in Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) in the 4th quarter, HoldingsChannel.com reports. The institutional investor acquired 12,672 shares of the biopharmaceutical company’s stock, valued at approximately $119,000. A number of other hedge funds have also added to or reduced their stakes in TBPH. Newtyn Management LLC […] - 2025-06-03 05:26:49
Ameriprise Financial Inc. Lowers Stock Holdings in Theravance Biopharma, Inc. (NASDAQ:TBPH): Ameriprise Financial Inc. reduced its stake in Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) by 9.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 100,807 shares of the biopharmaceutical company’s stock after selling 10,825 shares during the period. Ameriprise Financial Inc.’s holdings in […] - 2025-06-02 04:19:00
Man Group plc Sells 14,851 Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH): Man Group plc reduced its stake in shares of Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) by 59.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,328 shares of the biopharmaceutical company’s stock after selling 14,851 shares during the quarter. Man […] - 2025-05-29 05:36:58
Dimensional Fund Advisors LP Has $5.21 Million Holdings in Theravance Biopharma, Inc. (NASDAQ:TBPH): Dimensional Fund Advisors LP raised its position in Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) by 20.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 553,713 shares of the biopharmaceutical company’s stock after buying an additional 95,304 shares during the […] - 2025-05-13 06:14:52
Theravance Biopharma, Inc. (NASDAQ:TBPH) Shares Bought by Tower Research Capital LLC TRC: Tower Research Capital LLC TRC grew its position in Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) by 142.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 12,670 shares of the biopharmaceutical company’s stock after purchasing an additional 7,452 shares during the period. Tower Research Capital […] - 2025-05-09 05:22:54
Barclays PLC Raises Position in Theravance Biopharma, Inc. (NASDAQ:TBPH): Barclays PLC increased its position in shares of Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) by 14.0% in the 4th quarter, HoldingsChannel reports. The firm owned 74,790 shares of the biopharmaceutical company’s stock after purchasing an additional 9,210 shares during the period. Barclays PLC’s holdings in Theravance Biopharma were worth $704,000 as of its most […] - 2025-05-08 04:36:46
XTX Topco Ltd Reduces Stock Position in Theravance Biopharma, Inc. (NASDAQ:TBPH): XTX Topco Ltd lessened its holdings in Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) by 20.0% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 16,356 shares of the biopharmaceutical company’s stock after selling 4,083 shares during the period. XTX Topco Ltd’s holdings in Theravance […] - 2025-04-29 05:24:51
10,937 Shares in Theravance Biopharma, Inc. (NASDAQ:TBPH) Bought by Teacher Retirement System of Texas: Teacher Retirement System of Texas acquired a new position in Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 10,937 shares of the biopharmaceutical company’s stock, valued at approximately $103,000. Other institutional investors have […] - 2025-04-03 04:16:48
Theravance Biopharma, Inc. (NASDAQ:TBPH) Given Consensus Rating of “Hold” by Analysts: Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH – Get Free Report) have been assigned a consensus rating of “Hold” from the five brokerages that are covering the stock, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average twelve-month price […] - 2025-03-27 04:55:16
Bank of New York Mellon Corp Sells 5,282 Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH): Bank of New York Mellon Corp trimmed its stake in Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) by 4.4% during the fourth quarter, HoldingsChannel.com reports. The fund owned 115,779 shares of the biopharmaceutical company’s stock after selling 5,282 shares during the quarter. Bank of New York Mellon Corp’s holdings in Theravance Biopharma were worth $1,089,000 […] - 2025-03-25 05:14:50
Theravance Biopharma (NASDAQ:TBPH) Receives Buy Rating from HC Wainwright: HC Wainwright reaffirmed their buy rating on shares of Theravance Biopharma (NASDAQ:TBPH – Free Report) in a research report report published on Tuesday,Benzinga reports. They currently have a $15.00 price objective on the biopharmaceutical company’s stock. Theravance Biopharma Trading Up 1.2 % TBPH opened at $8.97 on Tuesday. Theravance Biopharma has a 12-month low of […] - 2025-02-26 06:49:00

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.